Burning Rock Biotech Ltd expected to post a loss of CNY2.41 a share - Earnings Preview

Burning Rock Biotech

27/05/2022 14:09

* Burning Rock Biotech Ltd  BNR.OQ   BNR.O  is expected
to show a
rise in quarterly revenue when it reports  results on May 31. 
    * The Guangzhou Guangdong-based  company is expected to
report  a
29.8% increase in revenue to CNY138.4 million from CNY106.62
million a year ago, according to the estimate from one analyst,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Burning Rock
Biotech Ltd
is for a loss of CNY2.41 per share. For the same quarter last
year, the company reported a loss of CNY1.65 per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Burning
Rock
Biotech Ltd is $13​, above​ its last closing price of $2.38. ​​​

This summary was machine generated May 27 at 13:09 GMT.  All
figures in Chinese yuan renminbi  unless otherwise stated